Justin Matthew Meche, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3521 Highway 190 Ste T, Eunice, LA 70535 Phone: 337-457-8980 Fax: 337-457-8983 |
Todd H Pullin, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 301 N Martin Luther King Dr, Eunice, LA 70535 Phone: 337-550-1175 Fax: 337-236-8073 |
Charice M Hebert, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3256 Hwy 190, Eunice, LA 70535 Phone: 337-550-8530 |
Dr. Kermen D. Beauchamp, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3521 Highway 190, Suite R, Eunice, LA 70535 Phone: 337-457-2301 |
Glenn Borne, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 168 Country Club Dr, Eunice, LA 70535 Phone: 337-457-8203 |
Nicole V Michael, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 151 Hill St, Eunice, LA 70535 Phone: 337-457-7798 Fax: 337-550-8020 |
News Archive
CLC bio, the world's leading bioinformatics solution provider, today announced a partnership with Ion Torrent, a new sequencing company started by Dr. Jonathan Rothberg, the founder of 454 Life Sciences. The partnership will ensure that data can directly flow off of the Ion Personal Genome Machine sequencer and into CLC bio's solutions, like CLC Genomics Workbench or CLC Genomics Server.
Researchers from McLean Hospital and Yale University have published findings of their study of large-scale systems in the brain, findings that could improve understanding of the symptoms and causes of bipolar disorder, schizophrenia, depression, and other mental illnesses.
Bill Gates, co-chair of the Bill & Melinda Gates Foundation, argues the case for polio eradication and expanded childhood immunization in his third annual letter released today. The letter, a personal account of his priorities, also calls on governments to invest in foreign aid, even in the face of a tough economic climate.
Results from an international Phase III study presented today at the International Liver CongressTM 2014 have shown obeticholic acid (OCA) given to patients suffering from Primary Biliary Cirrhosis (PBC) who previously had an inadequate response to, or have been unable to tolerate ursodeoxycholic acid (UDCA), produced meaningful biochemical and clinical improvements. UDCA is the only therapy currently approved to treat PBC.
› Verified 3 days ago